EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, CurveBeam AI's enterprise value is A$63.60 Mil.
CurveBeam AI's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$3.42 Mil. Therefore, CurveBeam AI's EV-to-Revenue for today is 18.61.
The historical rank and industry rank for CurveBeam AI's EV-to-Revenue or its related term are showing as below:
ASX:CVB'
s EV-to-Revenue Range Over the Past 10 Years
Min: 2.39 Med: 3.45 Max: 4.48
Current: 18.61
During the past 3 years, the highest EV-to-Revenue of CurveBeam AI was 4.48. The lowest was 2.39. And the median was 3.45.
ASX:CVB's EV-to-Revenue is ranked worse than 88.03% of 827
companies
in the Medical Devices & Instruments industry
Industry Median: 3.1
vs ASX:CVB: 18.61
As of today (2024-06-05), CurveBeam AI's stock price is A$0.20.
CurveBeam AI's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01. Therefore, CurveBeam AI's PS Ratio for today is 14.29.
CurveBeam AI EV-to-Revenue Historical Data
The historical data trend for CurveBeam AI's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
CurveBeam AI EV-to-Revenue Chart
CurveBeam AI Annual Data
Trend
Jun21
Jun22
Jun23
EV-to-Revenue
-
-
-
CurveBeam AI Semi-Annual Data
Jun21
Dec21
Jun22
Jun23
Dec23
EV-to-Revenue
-
-
-
-
-
Competitive Comparison of CurveBeam AI's EV-to-Revenue
For the Medical Devices subindustry, CurveBeam AI's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CurveBeam AI's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where CurveBeam AI's EV-to-Revenue falls into.
CurveBeam AI's current Enterprise Value is A$63.60 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CurveBeam AI's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was A$3.42 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CurveBeam AI's share price for today is A$0.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was A$0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CurveBeam AI EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of CurveBeam AI's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:CVB has been successfully added to your